Analystreport

Cardiome Pharma Corporation (NASDAQ: CRME) was upgraded by analysts at Mackie to a "buy" rating.

CARDIOME PHARMA CORP OR  (CRME) 
Last cardiome pharma corp or earnings: 5/15 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: cardiome.com/investors